Flexibility in Clinical Trials: Interview with: Prof Dr Geerd Weyer, Managing Director, ICRC-Weyer, a sponsor company at the marcus evans Evolution Summit 2012, on why drug development requires flexibility in the trial design.

1. Flexibility
in Clinical Trials
service providers. They tend to believe has always been one of cooperation
that the globalisation of drug and partnership with clients and other
development gives them strength and service providers; bringing together
allows them to avoid friction in our own strengths as a flexible
processes that they would have if they specialist with the strengths of other
had multiple interfaces and vendors. providers.
They believe that this will help them
save time and effort, but I consider Our philosophy is also reflected in the
this to be a one-sided view. way we integrate services across
departments. Likewise, our data
Using the services of a niche or systems are optimised to seamlessly
specialist provider could help them integrate data from various sources,
accelerate clinical development. internal or external.
Interview with: Prof Dr Geerd
Weyer, Managing Director, ICRC- Would this limit innovation in any
Weyer way?
Innovation in drug development
When it comes to innovation, a service
provider that can be flexible should be Processes must
be adapted
requires flexibility in the clinical trial preferred. Smaller organisations are
design, not merely standardisation, able to bring in study-specific
according to Prof Dr Geerd Weyer, solutions, while larger organisations
Managing Director, ICRC-Weyer.
Every trial is unique and must be
can bring in productivity and efficiency
as they are able to streamline and
to each study
designed and treated as such, he adds. standardise services.
From a contract research organisation There is a dichotomy between
attending the upcoming marcus efficiency and productivity on the one What is key to clinical research and
evans Evolution Summit 2012, Prof side, and innovation on the other. trial success?
Dr Weyer talks about clinical trials and However, standardisation does not
how adaptability can accelerate always work. Processes must be The key is to have the right data in
clinical development. adapted to each study. Clinical high quality when needed. This can be
development is a process where achieved by recognising the value that
What would accelerate drug innovation and flexibility are needed, at a specialist provider in that respective
development and delivery/time to least as much as standardisation. area can bring, and by not totally
market? relying on standard solutions.
What is unique about your
In the last few years, many large approach and philosophy? There is no single way for succeeding
pharmaceutical companies have been in clinical development. Every trial is
contracting out clinical development We are well aware of the dichotomy I unique and must be designed and
services to single, globally acting mentioned before, but our philosophy treated as such.

2. About the Evolution Summit 2012
The Pharma Network –
marcus evans Summits group
Offering much more than any conference, seminar or trade show, this exclusive
delivers peer-to-peer information
meeting will bring together esteemed industry thought leaders and solution
on strategic matters, professional
providers to a highly focused and interactive networking event.
trends and breakthrough
innovations.
www.evolution-summit.com
Contact
Please note that the Summit is a
Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits
closed business event and the
Division
number of participants strictly
limited.
Tel: + 357 22 849 313
Email: press@marcusevanscy.com
For more information please send an email to info@marcusevanscy.com
All rights reserved. The above content may be republished or reproduced. Kindly
inform us by sending an email to press@marcusevanscy.com
About ICRC-Weyer
Located in Berlin, Germany, ICRC-Weyer is an all-Phase CRO with almost 20 years experience. The company provides its services
for the pharmaceutical and nutrition industries. These center on specialist solutions for independent medical review, expert
consulting and pharmacovigilance, which are integrated with the data management, statistical analysis and medical and regulatory
writing packages being offered.
www.icrc-weyer.com
About marcus evans Summits
marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss
strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to
individually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings.
For more information, please visit: www.marcusevans.com
Upcoming Events
Discovery Summit (Europe) - www.discovery-summit.com
Discovery Summit (North America) - www.thediscoverysummit.com
Evolution Asia Summit - www.evolutionasia-summit.com
Evolution Summit (North America) - www.evolutionsummit.com.com
To view the web version of this interview, please click here: www.evolution-summit.com/GeerdWeyer